Navigation Links
Cognitive-behavioral therapy for insomnia can reduce suicidal ideation
Date:6/13/2011

DARIEN, IL Treating sleep problems with cognitive-behavioral therapy for insomnia can reduce suicidal ideation, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

Results show that about 21 percent of participants with insomnia (65 of 303) reported having suicidal thoughts or wishes during the past two weeks. Group cognitive-behavioral therapy for insomnia produced a statistically significant post-treatment reduction in suicidal ideation. Treatment sessions were conducted weekly until the final two sessions, which were conducted bi-weekly.

According to the authors, a growing body of evidence suggests that self-reported insomnia and poor sleep quality constitute modifiable risk factors for suicide. Sleep complaints also are listed among the top suicide warning signs by the Substance Abuse and Mental Health Service Administration. However, no previous studies had evaluated the impact of a sleep intervention on suicidal ideation.

"This is the first investigation to show that a sleep-targeted intervention has a therapeutic impact on suicide risk specifically," said lead author Rebecca Bernert, PhD, a fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University in California. "This suggests that a treatment focus on sleep disturbances may have important implications for the prevention of suicidal behaviors."

The study involved 303 community outpatients between 18 and 88 years of age who completed group cognitive behavioral therapy for insomnia. The Beck Depression Inventory, which includes a question about suicidal thoughts or wishes, was administered at both baseline and post-treatment.

According to the Centers for Disease Control and Prevention, the most recent data available indicate that the national suicide rate increased from 2008 to 2009, when suicide became the 10th-leading cause of death in the U.S. There were 36,547 deaths attributed to suicide in 2009, which was more than twice as many deaths as those that were attributed to homicide.

Last year at SLEEP 2010, Bernert reported that highly variable sleep schedules predicted increases in suicidal risk at one week and three weeks. Sleep irregularity also predicted greater mood lability, which in turn predicted elevated suicidal symptoms.


'/>"/>

Contact: Emilee McStay
emcstay@aasmnet.org
630-737-9700
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. Group therapy helps MS sufferers cope with depression, study finds
2. Cognitive Therapy Helps Depressed Drug Abusers
3. Tai chi could be key to overcoming cognitive effects of chemotherapy
4. Hormone test predicts ovarian function after chemotherapy for breast cancer
5. Targeted cancer therapy kills prostate tumor cells
6. Following colorectal cancer surgery, longer delay before chemotherapy associated with worse survival
7. Hormone deprivation therapy for prostate cancer may raise diabetes risk
8. Breast cancer surgery patients benefit from adding radiation therapy
9. Combination antibody therapy shows promise in metastatic melanoma
10. Benefit of targeted lung cancer therapy confirmed
11. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Saint Francis Hospital ... years, and the efforts have paid off. Since implementation of these efforts, ... care to enhance perioperative patient experiences and reduce costly complications. Since implementation in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Development Team of Pixel ... for FCPX. , "This new layered style transition tool will keep a consistent flow ... CEO of Pixel Film Studios. , TranSweep is an all new layered style ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug Administration ... both men and women. To date, the company is the first and only manufacturer ... adult who suffers with androgenetic alopecia. , “This new level of clearance substantiates ...
(Date:5/25/2016)... ... 25, 2016 , ... The Georgia State University College of Law new building ... Design Commission. , The annual award recognizes projects, programs, individuals and organizations that have ... of its physical heritage and the balance between the old and the new. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... today announced that Jeffrey H. Burbank , Chief ... of investor conferences. Where applicable, a webcast of the ...   ... Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology: